DE69822208D1 - Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus - Google Patents

Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus

Info

Publication number
DE69822208D1
DE69822208D1 DE69822208T DE69822208T DE69822208D1 DE 69822208 D1 DE69822208 D1 DE 69822208D1 DE 69822208 T DE69822208 T DE 69822208T DE 69822208 T DE69822208 T DE 69822208T DE 69822208 D1 DE69822208 D1 DE 69822208D1
Authority
DE
Germany
Prior art keywords
pushroom
administration system
restraint mechanism
osmotic administration
osmotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69822208T
Other languages
English (en)
Other versions
DE69822208T2 (de
Inventor
Rupal Ayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intarcia Therapeutics Inc
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DE69822208D1 publication Critical patent/DE69822208D1/de
Publication of DE69822208T2 publication Critical patent/DE69822208T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DE69822208T 1997-12-29 1998-12-15 Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus Expired - Lifetime DE69822208T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6898797P 1997-12-29 1997-12-29
US68987P 1997-12-29
PCT/US1998/026654 WO1999033446A1 (en) 1997-12-29 1998-12-15 Osmotic delivery system with membrane plug retention mechanism

Publications (2)

Publication Number Publication Date
DE69822208D1 true DE69822208D1 (de) 2004-04-08
DE69822208T2 DE69822208T2 (de) 2005-04-28

Family

ID=22085978

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69822208T Expired - Lifetime DE69822208T2 (de) 1997-12-29 1998-12-15 Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus

Country Status (13)

Country Link
US (5) US6270787B1 (de)
EP (1) EP1041968B1 (de)
JP (1) JP4173635B2 (de)
AR (1) AR014194A1 (de)
AT (1) ATE260640T1 (de)
AU (1) AU1828599A (de)
CA (1) CA2316976C (de)
DE (1) DE69822208T2 (de)
ES (1) ES2217613T3 (de)
HK (1) HK1031332A1 (de)
TW (1) TW446552B (de)
WO (1) WO1999033446A1 (de)
ZA (1) ZA9811880B (de)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
WO1999033446A1 (en) * 1997-12-29 1999-07-08 Alza Corporation Osmotic delivery system with membrane plug retention mechanism
NZ512671A (en) * 1998-12-31 2003-12-19 Alza Corp Osmotic delivery system having space efficient piston
US7919109B2 (en) * 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
WO2001045675A2 (en) * 1999-12-21 2001-06-28 Alza Corporation Valve for osmotic devices
US7163688B2 (en) * 2001-06-22 2007-01-16 Alza Corporation Osmotic implant with membrane and membrane retention means
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
EP1494998A2 (de) 2002-03-01 2005-01-12 University Of South Florida Mehrkomponenten festphasen enthaltend wenigstens einen pharmazeutischen wirkstoff
JP2005533782A (ja) * 2002-06-17 2005-11-10 アルザ コーポレイション 流体ビヒクル中に分散した浸透剤を含む、押出し力が早く零次になる機関を有する浸透送出システム
IL165383A0 (en) * 2002-06-21 2006-01-15 Transform Pharmaceuticals Inc Pharmaceutical compositions with improved dissolution
EP1551493B1 (de) 2002-06-26 2007-10-31 Alza Corporation Minimal nachgiebiger volumen-effizienter kolben für osmotische medikamentenabgabesysteme
US7014636B2 (en) * 2002-11-21 2006-03-21 Alza Corporation Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
RU2342118C2 (ru) * 2002-12-19 2008-12-27 Алза Корпорейшн Стабильные неводные однофазные гели и композиции на их основе для доставки из имплантируемого устройства
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EP2339328A3 (de) 2002-12-30 2011-07-13 Transform Pharmaceuticals, Inc. Pharmazeutische kokristallisierte Celecoxib-Zusammensetzungen
US8183290B2 (en) * 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
JP4923182B2 (ja) 2003-02-28 2012-04-25 マクニール−ピーピーシー・インコーポレーテツド セレコキシブ及びニコチンアミド共結晶並びにこの共結晶を含む医薬組成物
AR043811A1 (es) 2003-03-31 2005-08-17 Alza Corp Vehiculos de fase unica no acuosos y formulaciones que utilizan dichos vehiculos
WO2004089457A1 (en) * 2003-03-31 2004-10-21 Alza Corporation Osmotic pump with means for dissipating internal pressure
BRPI0408921A (pt) * 2003-03-31 2006-03-28 Alza Corp sistema de distribuição osmótico e método para diminuir os tempos de inìcio para os sistemas de distribuição osmóticos
WO2004091278A2 (en) * 2003-04-11 2004-10-28 Transform Pharmaceuticals, Inc. Gabapentin compositions
US7186863B2 (en) 2003-05-23 2007-03-06 Transform Pharmaceuticals, Inc. Sertraline compositions
NZ546148A (en) 2003-09-26 2009-05-31 Alza Corp Drug coating providing high drug loading and methods for providing the same
WO2005030181A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
CA2540047A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Oros push-stick for controlled delivery of active agents
AU2004275835B2 (en) 2003-09-26 2011-06-23 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
KR20060097008A (ko) * 2003-09-30 2006-09-13 알자 코포레이션 상승하는 방출 프로파일을 제공하는 삼투압으로 구동되는활성제 전달 장치
PL380763A1 (pl) 2003-10-31 2007-03-05 Alza Corporation Pompa osmotyczna z samoczynnie mocowanym korkiem membranowym szybkiego uruchamiania
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
US20050101943A1 (en) * 2003-11-06 2005-05-12 Alza Corporation Modular imbibition rate reducer for use with implantable osmotic pump
US7829552B2 (en) 2003-11-19 2010-11-09 Metabasis Therapeutics, Inc. Phosphorus-containing thyromimetics
WO2005092065A2 (en) * 2004-03-25 2005-10-06 Transform Pharmaceuticals, Inc. Novel tricyclic compounds and related methods of treatment
JP2007531145A (ja) * 2004-03-31 2007-11-01 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 制限されたバジェット使用の手法においてバジェットを転送する方法及びシステム
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
JP5017103B2 (ja) * 2004-06-17 2012-09-05 トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド 薬剤共結晶組成物および関連した使用方法
JP2008510558A (ja) 2004-08-27 2008-04-10 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 少なくとも１つの薬剤を投与する、電子制御され、遠隔制御されるピル及びシステム
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
WO2006073779A1 (en) * 2004-12-30 2006-07-13 Transform Phamaceuticals, Inc. Novel omeprazole forms and related methods
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006084139A2 (en) * 2005-02-03 2006-08-10 Intarcia Therapeutics, Inc. An implantable interferon-containing device
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US7959938B2 (en) * 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
AU2006265847A1 (en) * 2005-06-30 2007-01-11 Alza Corporation Osmotic intraosseous drug delivery system
US20070027105A1 (en) * 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US7931620B2 (en) * 2006-02-01 2011-04-26 Roche Diagnostics International Ag Self-sealing connection for housing shells of an administering device
EP2015805A1 (de) * 2006-04-28 2009-01-21 Koninklijke Philips Electronics N.V. Osmotische pumpe mit mindestens einem aufladbaren material
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
CN102274557B (zh) 2006-08-09 2014-12-03 精达制药公司 渗透性递送系统和活塞组件
US9114133B2 (en) 2006-08-25 2015-08-25 U.S. Dept. Of Veterans Affairs Method of improving diastolic dysfunction
US8617143B2 (en) * 2006-12-07 2013-12-31 The Regents Of The University Of California Therapeutic agent delivery systems and devices
KR20150008922A (ko) 2007-02-09 2015-01-23 메타베이시스 테라퓨틱스, 인크. 글루카곤 수용체의 길항제
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
MX2010001071A (es) * 2007-07-27 2010-03-09 Depomed Inc Formas de dosificacion retentivas gastricas pulsatiles.
MX2010001784A (es) 2007-08-13 2010-03-15 Metabasis Therapeutics Inc Activadores novedosos de la glucocinasa.
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
EP2326618B1 (de) 2008-08-13 2014-10-15 Metabasis Therapeutics, Inc. Glucagon-antagonisten
AU2009303905B2 (en) * 2008-10-15 2015-01-22 Intarcia Therapeutics, Inc. Highly concentrated drug particles, formulations, suspensions and uses thereof
EP2416834B1 (de) 2009-04-07 2013-10-16 Medimetrics Personalized Drug Delivery B.V. Modulare einnehmbare arzneiabgabekapsel
CN102481439B (zh) 2009-08-12 2014-06-25 皇家飞利浦电子股份有限公司 具有可压缩药品储存器的药品输送设备
AU2010298733B2 (en) 2009-09-28 2014-10-09 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
CA2794565C (en) 2010-04-08 2018-08-21 Emory University Substituted androst-4-ene diones
US9629644B2 (en) 2010-08-30 2017-04-25 SinuSys Corporation Devices and methods for dilating a paranasal sinus opening and for treating sinusitis
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CA2830069C (en) 2011-03-20 2019-11-12 The University Of British Columbia Therapeutic agent for emphysema and copd
WO2012129497A2 (en) * 2011-03-24 2012-09-27 MEDIMETRICS Personalized Drug Delivery B.V. Swallowable medication capsule
ITFI20110114A1 (it) 2011-05-31 2012-12-01 Scuola Superiore Di Studi Universit Arie Di Perfe Piattaforma robotica per chirurgia mininvasiva
WO2013003697A1 (en) 2011-06-30 2013-01-03 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
US20130090633A1 (en) * 2011-10-07 2013-04-11 University Of Southern California Osmotic patch pump
TWI615155B (zh) * 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
EP2819740A4 (de) 2012-02-29 2015-11-25 Sinusys Corp Vorrichtungen und verfahren zur dilatation einer paranasalen sinusöffnung und zur behandlung von sinusitis
US9737364B2 (en) 2012-05-14 2017-08-22 Vanderbilt University Local magnetic actuation of surgical devices
ES2592404T3 (es) 2012-05-21 2016-11-30 Bayer Pharma Aktiengesellschaft Benzotienopirimidinas sustituidas
US9826904B2 (en) 2012-09-14 2017-11-28 Vanderbilt University System and method for detecting tissue surface properties
US20140081169A1 (en) * 2012-09-17 2014-03-20 Vanderbilt University System and method of tetherless insufflation in colon capsule endoscopy
TW201412740A (zh) 2012-09-20 2014-04-01 Bayer Pharma AG 經取代之吡咯并嘧啶胺基苯并噻唑酮
CN102871982B (zh) 2012-10-16 2014-09-10 中国科学院上海药物研究所 一种药物渗透泵制剂
WO2014113697A1 (en) 2013-01-17 2014-07-24 Vanderbilt University Real-time pose and magnetic force detection for wireless magnetic capsule
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
WO2015027146A1 (en) 2013-08-22 2015-02-26 The General Hospital Corporation Inhibitors of human 12/15-lipoxygenase
WO2015191900A1 (en) 2014-06-12 2015-12-17 Ligand Pharmaceuticals, Inc. Glucagon antagonists
EP3190945A4 (de) 2014-09-09 2018-06-27 Vanderbilt University Hydro-jet-endoskopiekapsel und verfahren zum screening auf magenkrebs in umgebungen mit wenigen ressourcen
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CA2987766A1 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
AU2016349381B2 (en) 2015-11-05 2023-02-23 The General Hospital Corporation Intrathecal delivery of nucleic acid sequences encoding ABCD1 for treatment of adrenomyeloneuropathy
SG10201913699QA (en) 2016-05-16 2020-03-30 Intarcia Therapeutics Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
BR112019008021A2 (pt) 2016-10-20 2019-07-09 Peptron, Inc. métodos de distribuição de um polipeptídeo neuroprotetor ao sistema nervoso central
US10835580B2 (en) 2017-01-03 2020-11-17 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
MX2019010651A (es) 2017-03-08 2020-01-13 Intarcia Therapeutics Inc Aparato y métodos para administración de un compuesto nauseogénico desde un dispositivo de administración de fármacos.
US11122965B2 (en) 2017-10-09 2021-09-21 Vanderbilt University Robotic capsule system with magnetic actuation and localization
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
WO2020077129A1 (en) 2018-10-11 2020-04-16 Intarcia Therapeutics, Inc. Human amylin analog polypeptides and methods of use
US20200155466A1 (en) * 2018-11-21 2020-05-21 II Don S. Houtz Oral Medicine Delivery Capsule
CN109589491B (zh) * 2019-01-29 2024-01-09 上海安翰医疗技术有限公司 自动给药装置
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732865A (en) 1971-01-13 1973-05-15 Alza Corp Osmotic dispenser
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3929132A (en) * 1973-04-10 1975-12-30 Alza Corp Osmotic dispenser
US3995632A (en) 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US3916889A (en) 1973-09-28 1975-11-04 Sandoz Ag Patient ventilator apparatus
US3888249A (en) * 1973-11-02 1975-06-10 David L Spencer Arterial infusion catheter
US4111203A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4111202A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4203439A (en) 1976-11-22 1980-05-20 Alza Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4243030A (en) 1978-08-18 1981-01-06 Massachusetts Institute Of Technology Implantable programmed microinfusion apparatus
US4373527B1 (en) 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4340054A (en) 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4552561A (en) 1982-12-23 1985-11-12 Alza Corporation Body mounted pump housing and pump assembly employing the same
US4639244A (en) 1983-05-03 1987-01-27 Nabil I. Rizk Implantable electrophoretic pump for ionic drugs and associated methods
US4865845A (en) 1986-03-21 1989-09-12 Alza Corporation Release rate adjustment of osmotic or diffusional delivery devices
US4874388A (en) 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5151093A (en) 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
GB9027422D0 (en) 1990-12-18 1991-02-06 Scras Osmotically driven infusion device
US5137727A (en) 1991-06-12 1992-08-11 Alza Corporation Delivery device providing beneficial agent stability
US5223265A (en) 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US5456679A (en) 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5308348A (en) 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
US5980508A (en) * 1994-06-22 1999-11-09 Controlled Release Technologies Pty Ltd Controlled release device and method
US5731001A (en) * 1995-06-07 1998-03-24 Magruder; Judy A. Locking couplings for osmotic delivery devices
ATE281153T1 (de) 1996-02-02 2004-11-15 Alza Corp Implantierbares system mit verzögerter wirkstofffreisetzung
WO1999033446A1 (en) 1997-12-29 1999-07-08 Alza Corporation Osmotic delivery system with membrane plug retention mechanism
ES2273427T3 (es) * 1997-12-30 2007-05-01 Alza Corporation Sistema de suministro de un agente beneficioso con una membrana obturadora.

Also Published As

Publication number Publication date
EP1041968B1 (de) 2004-03-03
WO1999033446A1 (en) 1999-07-08
US20040243106A1 (en) 2004-12-02
JP2001526939A (ja) 2001-12-25
CA2316976C (en) 2009-02-17
HK1031332A1 (en) 2001-06-15
ES2217613T3 (es) 2004-11-01
EP1041968A1 (de) 2000-10-11
ZA9811880B (en) 1999-06-29
DE69822208T2 (de) 2005-04-28
US20010022974A1 (en) 2001-09-20
JP4173635B2 (ja) 2008-10-29
US6976981B2 (en) 2005-12-20
US6270787B1 (en) 2001-08-07
TW446552B (en) 2001-07-21
CA2316976A1 (en) 1999-07-08
US20010021822A1 (en) 2001-09-13
AU1828599A (en) 1999-07-19
US20050048097A1 (en) 2005-03-03
ATE260640T1 (de) 2004-03-15
AR014194A1 (es) 2001-02-07
US6899887B2 (en) 2005-05-31

Similar Documents

Publication Publication Date Title
DE69822208D1 (de) Osmotisches verabreichungssystem mit stöpselrückhaltemechanismus
DE69837439D1 (de) Osmotisches verabreichungssystem mit semipermeablem stöpsel
PT1051217E (pt) Sistema de controlo osmotico de administracao de medicamento
DE69810445D1 (de) Sitzbelegung-feststellungssystem
ATE259409T1 (de) Abgabesystem mit ablösesperrschicht beladenen zeolite
FI943168A0 (fi) Opioidiformulaatioita, joissa on pitkitetty säädelty vapautuminen
ATE291417T1 (de) Gastrointestinales wirkstoffverabreichungssystem
DK1030817T3 (da) Brændstofdispenseringssystem
ATE293816T1 (de) Sicherheitsvorrichtung mit mehreren sicherheitsmerkmalen
DE69822529D1 (de) Stentanbringungssystem
DK0862082T3 (da) Multiprojektionsystem
NO20001776D0 (no) Medikamenter
ID21702A (id) Sistim dispenser
DK0998272T3 (da) Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
DE69711045D1 (de) Vitamin c abgabesystem
BR9801027B1 (pt) sistema de distribuiÇço de medicamentos.
DE59706916D1 (de) Rückhaltesystem
DE19882431T1 (de) Zweifachbetrieb-Kamerasystem
DE69829254D1 (de) Arzneistoffzubereitung mit kontrollierter Wirkstofffreisetzungsrate
DE69818738D1 (de) Abwickelsystem mit Zentralantrieb
DE69814441D1 (de) 6,11-verbrückte erythromycinderivate
NL1006015A1 (nl) Toedieninrichting.
DE69800089D1 (de) Abgabesysteme
TR199800054A3 (tr) Tasit koltugu.
NL1009232A1 (nl) Projectiesysteem.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTARCIA THERAPEUTICS, INC., HAYWARD, CA, US